Differential impairment of vasodilator responsiveness of peripheral resistance and conduit vessels in humans with atherosclerosis.
about
Pleiotropic effects of statinsExercise rehabilitation in peripheral artery disease: functional impact and mechanisms of benefitsSecondary prevention of stroke and transient ischemic attack: is more platelet inhibition the answer?Thermotherapy reduces blood pressure and circulating endothelin-1 concentration and enhances leg blood flow in patients with symptomatic peripheral artery diseaseNoninvasive assessment of endothelial activity in patients with peripheral arterial disease and cardiovascular risk factors.Novel contactless approach for assessment of venous occlusion plethysmography by video recordings at the green illumination.Fluvastatin reduces proliferation and increases apoptosis in women with high grade breast cancer.Impairment of endothelium-dependent dilation is an early event in children with familial hypercholesterolemia and is related to the lipoprotein(a) level.Regulation of G-protein alpha i2 subunit expression by oxidized low-density lipoproteinAssociations of proanthocyanidin intake with renal function and clinical outcomes in elderly womenChronic hindlimb ischemia impairs functional vasodilation and vascular reactivity in mouse feed arteries.Pleiotropic effects of statins: moving beyond cholesterol control.A Novel Index Using Ankle Hemodynamic Parameters to Assess the Severity of Peripheral Arterial Disease: A Pilot StudyEffects of statins on 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition beyond low-density lipoprotein cholesterol.Vascular smooth muscle responsiveness to nitric oxide is reduced in healthy adults with increased adiposityShould all diabetic patients receive statins?Impaired Coronary Endothelial Vasorelaxation in a Preclinical Model of Peripheral Arterial InsufficiencyNitric oxide function in atherosclerosisPeripheral artery disease is associated with severe impairment of vascular functionPleiotropic effects of statin therapy: molecular mechanisms and clinical results.Translational therapeutics of dipyridamole.Additive effects of statin and dipyridamole on cerebral blood flow and stroke protectionSecoisolariciresinol diglucoside induces neovascularization-mediated cardioprotection against ischemia-reperfusion injury in hypercholesterolemic myocardium.Antioxidative effects of statins.Arterial dysfunction and functional performance in patients with peripheral artery disease: a review.Nitric oxide and reactive oxygen species in limb vascular function: what is the effect of physical activity?Current therapies and investigational drugs for peripheral arterial disease.Cardiovascular disease risk factors and blood pressure response during exercise in healthy children and adolescents: the European Youth Heart Study.Differential inhibition by NG-monomethyl-L-arginine of vasodilator effects of acetylcholine and methacholine in human forearm vasculature.Sodium-calcium exchange mediated contraction in left anterior descending and left ventricular branch arteries.Endothelin-1 levels predict 3-year survival in patients who have amputation for critical leg ischaemia.Vasodilatory capacity and vascular structure in long-standing hypertension: a LIFE substudy. Losartan Intervention For Endpoint-Reduction in Hypertension.Shockwave therapy in patients with peripheral artery disease.Participation of K+ channels in the endothelium-dependent and endothelium-independent components of the relaxant effect of rosuvastatin in rat aortic rings.Doppler ultrasound assessment of posterior tibial artery size in humans.Cutaneous microcirculatory function predicts the responsiveness to tadalafil in patients with erectile dysfunction and coronary artery disease.
P2860
Q24647863-D221E86E-7FC1-4935-9589-4902850F63B7Q27694706-D8C003DF-32C9-43A6-B313-39F586ECC8FAQ28221595-9B0EBC24-6E94-4160-84C4-A6B722A8AF3AQ31110191-120C6915-EA05-4421-802A-EA75985F9AEFQ33301912-09A15CBB-749B-49F5-A368-D0AD5AC23824Q33673684-937E22EC-3BA5-44A4-ACBE-E38FA475948CQ33864834-87AACA1B-4220-4675-8A04-8AF5429A9DA5Q34118495-52820C41-5E7E-43A2-BE2D-8763807FAA41Q34206300-FBE557AF-2977-4FF7-8602-E57D1133AB30Q34936957-620B304C-5FF1-4A25-B9C4-90AE5F885272Q35593182-AAE18F0C-514B-454B-8510-A9DA7E1FEBA4Q36025981-00E7C011-6C27-4546-A6B4-6C3C50E933BBQ36167870-7BEA5661-B3B1-4F67-B00C-1B5D83E77619Q36242351-A33FACBC-7720-4C8E-9037-1B92E11E656EQ36309275-56F75E0A-5300-4284-AE35-A191F69EEF83Q36385133-F2F6E710-1521-431F-BCBB-01433CF9D856Q36418319-102B8826-0D76-4B18-B1ED-068DEDDC5E44Q36628207-12D1BD41-0DAF-4A7C-99F7-8526FC34B771Q36959476-A6C6E7F3-4860-48B3-BD0E-C2EE1902BD78Q37027838-C32540B5-BCAF-4C29-8196-30E255644FD4Q37041703-6D8999F6-B3E4-4C2B-AEC5-0850A764DB27Q37142511-CDEB17B4-D30F-408B-9284-2238D2DAA64FQ37226354-951BBF84-C246-4EB2-A999-DBFB6FA91690Q37231791-4521E138-160A-4D0D-A97F-1640E255646FQ37859157-FCDE9D0A-BBAC-4CE5-9ABE-C9A45ECCC755Q38130310-F46485FC-7D69-4C35-BA04-69A8E0924797Q38657444-2856D730-EC06-4ED3-8FA2-1497745108A7Q39856526-5018405D-3D24-4FCE-9E2B-107661A50A5BQ41812180-DA705B49-0684-4460-BE1C-4CF0A07583F1Q42043667-D7510848-E7BF-4672-8D78-24B05D391700Q43950980-B9277ACE-AB22-4B3B-B80C-FD2D04EE2C6CQ44001351-F99D25FB-5A74-49E3-8FD3-340A59B6FC58Q44352275-4BAA4D61-A852-44BB-9D1A-FA7E462F3AEEQ46477436-74606AAE-D379-4E86-9882-7ED25C70F602Q47338930-118EC203-8BC7-4691-847E-D46B45D57EBDQ50682697-A345B326-2450-460B-BE67-FB7AD0363503
P2860
Differential impairment of vasodilator responsiveness of peripheral resistance and conduit vessels in humans with atherosclerosis.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年学术文章
@wuu
1991年学术文章
@zh
1991年学术文章
@zh-cn
1991年学术文章
@zh-hans
1991年学术文章
@zh-my
1991年学术文章
@zh-sg
1991年學術文章
@yue
1991年學術文章
@zh-hant
name
Differential impairment of vas ...... n humans with atherosclerosis.
@en
Differential impairment of vas ...... n humans with atherosclerosis.
@nl
type
label
Differential impairment of vas ...... n humans with atherosclerosis.
@en
Differential impairment of vas ...... n humans with atherosclerosis.
@nl
prefLabel
Differential impairment of vas ...... n humans with atherosclerosis.
@en
Differential impairment of vas ...... n humans with atherosclerosis.
@nl
P2093
P356
P1433
P1476
Differential impairment of vas ...... n humans with atherosclerosis.
@en
P2093
P304
P356
10.1161/01.RES.68.4.1027
P577
1991-04-01T00:00:00Z